Funding Clinical Trials

Funding Clinical Trials

Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.

CIRM Clinical Dashboard

Disease Areassort descending Investigator Organization Phase Trial Status Targeted Enrollment Detail
Kristen Johnson Calibr Phase 1 Completed 60
  • Bladder or Urinary Tract Disorder
 James Yoo Wake Forest University Health Sciences Phase 1 Not yet recruiting 10
Irving Weissman Stanford University Phase 1 Completed 88
John Zaia City of Hope, Beckman Research Institute Phase 1 Launching N/A
William van der Touw Celularity Inc Phase 1/2 Active, not recruiting 86
Stephanie Cherqui University of California, San Diego Phase 1/2 Recruiting 6
Donald Kohn University of California, Los Angeles Phase 2 Completed 10
Steven Deeks University of California, San Francisco Phase 1/2 Launching N/A
  • Immune Disease
  • Pediatrics
  • X-linked Chronic Granulomatous Disease
 Donald Kohn University of California, Los Angeles Phase 1/2 Active, not recruiting 16
Stephen Gottschalk St. Jude Children's Research Hospital Phase 1/2 Recruiting 28
Judith Shizuru Stanford University Phase 1/2 Recruiting 40
  • Immune Disease
  • Leukocyte Adhesion Deficiency
 Kinnari Patel Rocket Pharmaceuticals, Inc. Phase 1/2 Active, not recruiting 9
  • Muscle Injury
 Peter Belafsky University of California, Davis Phase 1/2 Recruiting 62
Donald Kohn University of California, Los Angeles Phase 1 Recruiting 6
  • Pulmonary Hypertension
  • Vascular Disease
 Michael Lewis Cedars-Sinai Medical Center Phase 1/2 Active, not recruiting 26
Dennis Slamon University of California, Los Angeles Phase 1 Completed 48
Icon for XLSX export